Citation: Yujie Li, Ya-Nan Wang, Yin-Gen Luo, Hongcai Yang, Jinrui Ren, Xiao Li. Advances in synthetic biology-based drug delivery systems for disease treatment[J]. Chinese Chemical Letters, ;2024, 35(11): 109576. doi: 10.1016/j.cclet.2024.109576 shu

Advances in synthetic biology-based drug delivery systems for disease treatment

Yujie Li ^a ,
Ya-Nan Wang ^b ,
Yin-Gen Luo ^a ,
Hongcai Yang ^a ,
Jinrui Ren ^a ,
Xiao Li ^{a, *,}

a.
Department of Interventional Therapy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
b.
Department of Radiology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450003, China

lixiao@cicams.ac.cn

Received Date: 5 December 2023
Revised Date: 17 January 2024
Accepted Date: 21 January 2024
Available Online: 29 January 2024

Figures(5)

With the increasing demand for personalized and precise treatment, the rapid advancement of synthetic biology technology has inevitably led to the development of nanobiology-based drug delivery systems. Synthetic biology-based drug delivery systems are being increasingly used in the treatment of various diseases. On one hand, synthetic biology technology enables the clever combination of chassis cells, bacteria, and their derivatives with nanomaterials, forming nano-artificial hybrid systems. These systems effectively integrate the functions of both materials, leading to further breakthroughs and optimization of biological functions. On the other hand, synthetic biology strategies guide the self-assembly of modular nanocomponents with biocatalytic or intelligent response functions, resulting in the mimicry of living cell features such as compartmentalization of enzymatic reactions and responsiveness to external stimuli. This provides novel design ideas for the construction of artificial cells. This paper aims to explore the construction and application of biogenic drug delivery systems based on whole cells, cell membrane-encapsulated nanoparticles, exosomes, bacteria, bacterial outer membrane vesicles and artificial cells, taking into account recent advances in this field. The advantages and limitations of current synthetic biology-based nanodrug delivery systems for clinical translation are discussed, and the future prospects of nanotechnology for intelligent drug diagnostic and therapeutic systems are envisioned.
- Drug delivery system,
- Synthetic biology,
- Nanotechnology,
- Genetic engineering,
- Nanoparticles
1. [1]
  K. Strebhardt, A. Ullrich, Nat. Rev. Cancer 8 (2008) 473–480. doi: 10.1038/nrc2394
2. [2]
  R.S. Schwartz, N. Engl. J. Med. 350 (2004) 1079–1080. doi: 10.1056/NEJMp048021
3. [3]
  X. You, L. Wang, J. Zhang, et al., Chin. Chem. Lett. 34 (2023) 107720. doi: 10.1016/j.cclet.2022.07.063
4. [4]
  J. Huang, X. You, P. Xin, et al., Chin. Chem. Lett. 32 (2021) 1737–1742. doi: 10.1016/j.cclet.2020.12.006
5. [5]
  Z. Fang, X. Zhang, H. Huang, J. Wu, Chin. Chem. Lett. 33 (2022) 1693–1704. doi: 10.1016/j.cclet.2021.11.050
6. [6]
  Y.B. Meng, J. Wu, Chin. J. Polym. Sci. 40 (2022) 1016–1027. doi: 10.1007/s10118-022-2701-9
7. [7]
  R. Chen, P. Ouyang, L. Su, et al., Chin. Chem. Lett. 33 (2022) 4610–4616. doi: 10.1016/j.cclet.2022.03.074
8. [8]
  J. Zhang, J. Yan, Y. Wang, et al., Chin. Chem. Lett. 35 (2024) 108434. doi: 10.1016/j.cclet.2023.108434
9. [9]
  S. Waheed, Z. Li, F. Zhang, et al., J. Nanobiotechnology 20 (2022) 395. doi: 10.1186/s12951-022-01605-4
10. [10]
  P. Couvreur, Adv. Drug Del. Rev. 65 (2013) 21–23. doi: 10.1016/j.addr.2012.04.010
11. [11]
  K. Park, ACS Nano 7 (2013) 7442–7447. doi: 10.1021/nn404501g
12. [12]
  E. Blanco, H. Shen, M. Ferrari, Nat. Biotechnol. 33 (2015) 941–951. doi: 10.1038/nbt.3330
13. [13]
  F.S. Collins, H. Varmus, N. Engl. J. Med. 372 (2015) 793–795. doi: 10.1056/NEJMp1500523
14. [14]
  O.S. Fenton, K.N. Olafson, P.S. Pillai, et al., Adv. Mater. 30 (2018) 1705328. doi: 10.1002/adma.201705328
15. [15]
  S. Hirschi, T.R. Ward, W.P. Meier, et al., Chem. Rev. 122 (2022) 16294–16328. doi: 10.1021/acs.chemrev.2c00339
16. [16]
  S.A. Benner, A.M. Sismour, Nat. Rev. Genet. 6 (2005) 533–543.
17. [17]
  N. Zhao, Y. Song, X. Xie, et al., Signal Transduct. Target Ther. 8 (2023) 112. doi: 10.1038/s41392-023-01375-x
18. [18]
  A.S. Khalil, J.J. Collins, Nat. Rev. Genet. 11 (2010) 367–379.
19. [19]
  H. Pick, A.C. Alves, H. Vogel, Chem. Rev. 118 (2018) 8598–8654. doi: 10.1021/acs.chemrev.7b00777
20. [20]
  H. Jia, P. Schwille, Curr. Opin. Biotechnol. 60 (2019) 179–187. doi: 10.1016/j.copbio.2019.05.008
21. [21]
  B.C. Buddingh, J.C.M. van Hest, Acc. Chem. Res. 50 (2017) 769–777. doi: 10.1021/acs.accounts.6b00512
22. [22]
  B. An, Y. Wang, Y. Huang, et al., Chem. Rev. 123 (2023) 2349–2419. doi: 10.1021/acs.chemrev.2c00512
23. [23]
  W. Li, X. Zhang, C. Zhang, et al., Nat. Commun. 12 (2021) 7264. doi: 10.1038/s41467-021-27434-x
24. [24]
  R. Kojima, D. Bojar, G. Rizzi, et al., Nat. Commun. 9 (2018) 1305. doi: 10.1038/s41467-018-03733-8
25. [25]
  W. Jiang, Z. Wu, Z. Gao, et al., ACS Nano 16 (2022) 15705–15733. doi: 10.1021/acsnano.2c06104
26. [26]
  F. Lussier, O. Staufer, I. Platzman, J.P. Spatz, Trends Biotechnol. 39 (2021) 445–459. doi: 10.1016/j.tibtech.2020.08.002
27. [27]
  A. Cubillos-Ruiz, T. Guo, A. Sokolovska, et al., Nat. Rev. Drug Discov. 20 (2021) 941–960. doi: 10.1038/s41573-021-00285-3
28. [28]
  L. Yang, Y. Yang, Y. Chen, et al., Adv. Drug Del. Rev. 187 (2022) 114394. doi: 10.1016/j.addr.2022.114394
29. [29]
  Q. Lu, T. Liu, Z. Han, et al., J. Control. Release 361 (2023) 604–620. doi: 10.1016/j.jconrel.2023.08.023
30. [30]
  S. Tan, T. Wu, D. Zhang, Z. Zhang, Theranostics 5 (2015) 863–881. doi: 10.7150/thno.11852
31. [31]
  M.Y. Thanuja, C. Anupama, S.H. Ranganath, Adv. Drug Del. Rev. 132 (2018) 57–80. doi: 10.1016/j.addr.2018.06.012
32. [32]
  H.Y. Chen, J. Deng, Y. Wang, et al., Acta Biomater. 112 (2020) 1–13. doi: 10.1016/j.actbio.2020.05.028
33. [33]
  Z. Wu, H. Zhang, J. Yan, et al., Theranostics 13 (2023) 20–39. doi: 10.7150/thno.76894
34. [34]
  H.H. Wu, Y. Zhou, Y. Tabata, J.Q. Gao, J. Control. Release 294 (2019) 102–113. doi: 10.1016/j.jconrel.2018.12.019
35. [35]
  C. Tran, M.S. Damaser, Adv. Drug Del. Rev. 82-83 (2015) 1–11.
36. [36]
  B. Crivelli, T. Chlapanidas, S. Perteghella, et al., J. Control. Release 262 (2017) 104–117. doi: 10.1016/j.jconrel.2017.07.023
37. [37]
  L. Fu, H.N. Kim, J.D. Sterling, et al., Adv. Drug Del. Rev. 184 (2022) 114195. doi: 10.1016/j.addr.2022.114195
38. [38]
  Q. Xia, Y. Zhang, Z. Li, et al., Acta Pharm. Sin. B 9 (2019) 675–689. doi: 10.1016/j.apsb.2019.01.011
39. [39]
  P.H.D. Nguyen, M.K. Jayasinghe, A.H. Le, et al., ACS Nano 17 (2023) 5187–5210. doi: 10.1021/acsnano.2c11965
40. [40]
  J.S. Brenner, S. Mitragotri, V.R. Muzykantov, Annu. Rev. Biomed. Eng. 23 (2021) 225–248. doi: 10.1146/annurev-bioeng-121219-024239
41. [41]
  A. Choi, K. Javius-Jones, S. Hong, H. Park, Int. J. Nanomedicine 18 (2023) 509–525. doi: 10.2147/IJN.S394389
42. [42]
  X. Dong, D. Chu, Z. Wang, Theranostics 7 (2017) 751–763. doi: 10.7150/thno.18069
43. [43]
  K. Jin, Z. Luo, B. Zhang, Z. Pang, Acta Pharm. Sin. B 8 (2018) 23–33. doi: 10.1016/j.apsb.2017.12.002
44. [44]
  Y.S. Zhu, K. Tang, J. Lv, Trends Pharmacol. Sci. 42 (2021) 857–869. doi: 10.1016/j.tips.2021.07.001
45. [45]
  S. Sharma, M.K. Masud, Y.V. Kaneti, et al., Small 17 (2021) e2102220. doi: 10.1002/smll.202102220
46. [46]
  F. Pierigè, S. Serafini, L. Rossi, M. Magnani, Adv. Drug Del. Rev. 60 (2008) 286–295. doi: 10.1016/j.addr.2007.08.029
47. [47]
  L. Labanieh, R.G. Majzner, C.L. Mackall, Nat. Biomed. Eng. 2 (2018) 377–391. doi: 10.1038/s41551-018-0235-9
48. [48]
  J. Wei, Y. Guo, Y. Wang, et al., Cell. Mol. Immunol. 18 (2021) 792–804. doi: 10.1038/s41423-020-00555-x
49. [49]
  R.C. Larson, M.V. Maus, Nat. Rev. Cancer 21 (2021) 145–161. doi: 10.1038/s41568-020-00323-z
50. [50]
  R.C. Sterner, R.M. Sterner, Blood Cancer J. 11 (2021) 69. doi: 10.1038/s41408-021-00459-7
51. [51]
  A. Dimitri, F. Herbst, J.A. Fraietta, Mol. Cancer 21 (2022) 78. doi: 10.1186/s12943-022-01559-z
52. [52]
  Q. Liu, J. Li, H. Zheng, et al., Mol. Cancer 22 (2023) 28. doi: 10.1186/s12943-023-01735-9
53. [53]
  M.M. Billingsley, N. Singh, P. Ravikumar, et al., Nano Lett. 20 (2020) 1578–1589. doi: 10.1021/acs.nanolett.9b04246
54. [54]
  Q. Chen, Q. Hu, E. Dukhovlinova, et al., Adv. Mater. 31 (2019) e1900192. doi: 10.1002/adma.201900192
55. [55]
  W. Ma, D. Zhu, J. Li, et al., Theranostics 10 (2020) 1281–1295. doi: 10.7150/thno.40291
56. [56]
  S. Srivastava, S.N. Furlan, C.A. Jaeger-Ruckstuhl, et al., Cancer Cell 39 (2021) 193–208. doi: 10.1016/j.ccell.2020.11.005
57. [57]
  S. Harmsen, E.I. Medine, M. Moroz, et al., Biomaterials 269 (2021) 120630. doi: 10.1016/j.biomaterials.2020.120630
58. [58]
  D. Zou, Z. Wu, X. Yi, et al., Proc. Natl. Acad. Sci. U. S. A. 120 (2023) e2214757120. doi: 10.1073/pnas.2214757120
59. [59]
  Q. Jiang, Y. Liu, R. Guo, et al., Biomaterials 192 (2019) 292–308. doi: 10.1016/j.biomaterials.2018.11.021
60. [60]
  Q. Zhang, D. Dehaini, Y. Zhang, et al., Nat. Nanotechnol. 13 (2018) 1182–1190. doi: 10.1038/s41565-018-0254-4
61. [61]
  P. Dash, A.M. Piras, M. Dash, J. Control. Release 327 (2020) 546–570. doi: 10.1016/j.jconrel.2020.09.012
62. [62]
  R.H. Fang, A.V. Kroll, W. Gao, L. Zhang, Adv. Mater. 30 (2018) e1706759. doi: 10.1002/adma.201706759
63. [63]
  N. Mohandas, P.G. Gallagher, Blood 112 (2008) 3939–3948.
64. [64]
  C. Liu, X. Liu, X. Xiang, et al., Nat. Nanotechnol. 17 (2022) 531–540. doi: 10.1038/s41565-022-01098-0
65. [65]
  Y. Jiang, N. Krishnan, J. Zhou, et al., Adv. Mater. 32 (2020) e2001808. doi: 10.1002/adma.202001808
66. [66]
  X. Zhang, Y. Kang, J. Wang, et al., Adv. Mater. 32 (2020) e1907692. doi: 10.1002/adma.201907692
67. [67]
  J. Ma, S. Zhang, J. Liu, et al., Small 15 (2019) e1902011. doi: 10.1002/smll.201902011
68. [68]
  S. Liu, J. Wu, Y. Feng, et al., Bioact. Mater. 22 (2023) 211–224.
69. [69]
  M. Xu, T. Feng, B. Liu, et al., Theranostics 11 (2021) 8926–8944. doi: 10.7150/thno.62330
70. [70]
  O.P.B. Wiklander, M. Á. Brennan, J. Lötvall, et al., Sci. Transl. Med. 11 (2019) eaav8521. doi: 10.1126/scitranslmed.aav8521
71. [71]
  I. Kimiz-Gebologlu, S.S. Oncel, J. Control. Release 347 (2022) 533–543. doi: 10.1016/j.jconrel.2022.05.027
72. [72]
  I.K. Herrmann, M.J.A. Wood, G. Fuhrmann, Nat. Nanotechnol. 16 (2021) 748–759. doi: 10.1038/s41565-021-00931-2
73. [73]
  L. Barile, G. Vassalli, Pharmacol. Ther. 174 (2017) 63–78. doi: 10.1016/j.pharmthera.2017.02.020
74. [74]
  E.V. Batrakova, M.S. Kim, J. Control. Release 219 (2015) 396–405. doi: 10.1016/j.jconrel.2015.07.030
75. [75]
  S. Salunkhe, M. Basak Dheeraj, et al., J. Control. Release 326 (2020) 599–614. doi: 10.1016/j.jconrel.2020.07.042
76. [76]
  Z. Yang, J. Shi, J. Xie, et al., Nat. Biomed. Eng. 4 (2020) 69–83.
77. [77]
  P.H.L. Tran, D. Xiang, T.T.D. Tran, et al., Adv. Mater. 32 (2020) e1904040. doi: 10.1002/adma.201904040
78. [78]
  Q. Wu, S. Fu, H. Xiao, et al., Adv. Sci. 10 (2023) e2204814. doi: 10.1002/advs.202204814
79. [79]
  J. Guo, F. Wang, Y. Hu, et al., Cell Rep. Med. 4 (2023) 100881. doi: 10.1016/j.xcrm.2022.100881
80. [80]
  T. Bu, Z. Li, Y. Hou, et al., Theranostics 11 (2021) 9988–10000. doi: 10.7150/thno.64229
81. [81]
  R. Tenchov, J.M. Sasso, X. Wang, et al., ACS Nano 16 (2022) 17802–17846. doi: 10.1021/acsnano.2c08774
82. [82]
  H. Duan, Y. Liu, Z. Gao, W. Huang, Acta Pharm. Sin. B 11 (2021) 55–70. doi: 10.1016/j.apsb.2020.09.016
83. [83]
  S.M. van Dommelen, P. Vader, S. Lakhal, et al., J. Control. Release 161 (2012) 635–644. doi: 10.1016/j.jconrel.2011.11.021
84. [84]
  S. Liu, X. Chen, L. Bao, et al., Nat. Biomed. Eng. 4 (2020) 1063–1075. doi: 10.1038/s41551-020-00637-1
85. [85]
  J. Wang, W. Tang, M. Yang, et al., Biomaterials 273 (2021) 120784. doi: 10.1016/j.biomaterials.2021.120784
86. [86]
  J. Du, Z. Wan, C. Wang, et al., Theranostics 11 (2021) 8185–8196. doi: 10.7150/thno.59121
87. [87]
  Y. Guo, Z. Wan, P. Zhao, et al., J. Nanobiotechnology 19 (2021) 402. doi: 10.1186/s12951-021-01145-3
88. [88]
  D. Deng, X. Li, J.J. Zhang, et al., ACS Nano 17 (2023) 8530–8550. doi: 10.1021/acsnano.3c00839
89. [89]
  C. Gong, X. Zhang, M. Shi, et al., Adv. Sci. 8 (2021) 2002787. doi: 10.1002/advs.202002787
90. [90]
  L. Alvarez-Erviti, Y. Seow, H. Yin, et al., Nat. Biotechnol. 29 (2011) 341–345. doi: 10.1038/nbt.1807
91. [91]
  X. Gao, N. Ran, X. Dong, et al., Sci. Transl. Med. 10 (2018) eaat0195. doi: 10.1126/scitranslmed.aat0195
92. [92]
  Q. Cheng, X. Shi, M. Han, et al., J. Am. Chem. Soc. 140 (2018) 16413–16417. doi: 10.1021/jacs.8b10047
93. [93]
  F. Wu, J. Liu, Adv. Drug Del. Rev. 188 (2022) 114443. doi: 10.1016/j.addr.2022.114443
94. [94]
  N.S. McCarty, R. Ledesma-Amaro, Trends Biotechnol 37 (2019) 181–197. doi: 10.1016/j.tibtech.2018.11.002
95. [95]
  S.R. Kang, D.H. Nguyen, S.W. Yoo, J.J. Min, Adv. Drug Del. Rev. 181 (2022) 114085. doi: 10.1016/j.addr.2021.114085
96. [96]
  H. Shen, N. Aggarwal, K.S. Wun, et al., Adv. Drug Del. Rev. 187 (2022) 114364. doi: 10.1016/j.addr.2022.114364
97. [97]
  F. Farjadian, M. Moghoofei, S. Mirkiani, et al., Biotechnol. Adv. 36 (2018) 968–985. doi: 10.1016/j.biotechadv.2018.02.016
98. [98]
  N.S. Forbes, Nat. Rev. Cancer 10 (2010) 785–794. doi: 10.1038/nrc2934
99. [99]
  C. Yang, M. Cui, Y. Zhang, et al., Commun. Biol. 3 (2020) 561. doi: 10.1038/s42003-020-01287-4
100. [100]
  F. Chen, Z. Zang, Z. Chen, et al., Biomaterials 214 (2019) 119226. doi: 10.1016/j.biomaterials.2019.119226
101. [101]
  B.W. Park, J. Zhuang, O. Yasa, M. Sitti, ACS Nano 11 (2017) 8910–8923. doi: 10.1021/acsnano.7b03207
102. [102]
  S. Chowdhury, S. Castro, C. Coker, et al., Nat. Med. 25 (2019) 1057–1063. doi: 10.1038/s41591-019-0498-z
103. [103]
  C.R. Gurbatri, I. Lia, R. Vincent, et al., Sci. Transl. Med. 12 (2020) eaax0876. doi: 10.1126/scitranslmed.aax0876
104. [104]
  M. Toyofuku, N. Nomura, L. Eberl, Nat. Rev. Microbiol. 17 (2019) 13–24. doi: 10.1038/s41579-018-0112-2
105. [105]
  M. Li, H. Zhou, C. Yang, et al., J. Control. Release 323 (2020) 253–268. doi: 10.1016/j.jconrel.2020.04.031
106. [106]
  M.G. Sartorio, E.J. Pardue, M.F. Feldman, M.F. Haurat, Annu. Rev. Microbiol. 75 (2021) 609–630. doi: 10.1146/annurev-micro-052821-031444
107. [107]
  M. Kaparakis-Liaskos, R.L. Ferrero, Nat. Rev. Immunol. 15 (2015) 375–387. doi: 10.1038/nri3837
108. [108]
  Q. Feng, X. Ma, K. Cheng, et al., Adv. Mater. 34 (2022) e2206200. doi: 10.1002/adma.202206200
109. [109]
  O.Y. Kim, H.T. Park, N.T.H. Dinh, et al., Nat. Commun. 8 (2017) 626. doi: 10.1038/s41467-017-00729-8
110. [110]
  C. Schwechheimer, M.J. Kuehn, Nat. Rev. Microbiol. 13 (2015) 605–619. doi: 10.1038/nrmicro3525
111. [111]
  V. Gujrati, S. Kim, S.H. Kim, et al., ACS Nano 8 (2014) 1525–1537. doi: 10.1021/nn405724x
112. [112]
  R.C. Laughlin, R.C. Alaniz, Gut Microbes 7 (2016) 450–454. doi: 10.1080/19490976.2016.1222345
113. [113]
  M.J.H. Gerritzen, D.E. Martens, R.H. Wijffels, et al., Biotechnol. Adv. 35 (2017) 565–574. doi: 10.1016/j.biotechadv.2017.05.003
114. [114]
  K. Cheng, R. Zhao, Y. Li, et al., Nat. Commun. 12 (2021) 2041. doi: 10.1038/s41467-021-22308-8
115. [115]
  S. Qing, C. Lyu, L. Zhu, et al., Adv. Mater. 32 (2020) e2002085. doi: 10.1002/adma.202002085
116. [116]
  Y. Li, K. Zhang, Y. Wu, et al., Small 18 (2022) e2107461. doi: 10.1002/smll.202107461
117. [117]
  Q. Guo, X. Li, W. Zhou, et al., ACS Nano 15 (2021) 13826–13838. doi: 10.1021/acsnano.1c05613
118. [118]
  L.H. Peng, M.Z. Wang, Y. Chu, et al., Sci. Adv. 6 (2020) eaba2735. doi: 10.1126/sciadv.aba2735
119. [119]
  Y. Li, R. Zhao, K. Cheng, et al., ACS Nano 14 (2020) 16698–16711. doi: 10.1021/acsnano.0c03776
120. [120]
  T. Ozdemir, A.J.H. Fedorec, T. Danino, C.P. Barnes, Cell Syst. 7 (2018) 5–16. doi: 10.1016/j.cels.2018.06.008
121. [121]
  Y. Elani, Angew. Chem. Int. Ed. 60 (2021) 5602–5611. doi: 10.1002/anie.202006941
122. [122]
  R.A. Meyer, J.C. Sunshine, J.J. Green, Trends Biotechnol. 33 (2015) 514–524. doi: 10.1016/j.tibtech.2015.07.001
123. [123]
  S. Toda, L.R. Blauch, S.K.Y. Tang, et al., Science 361 (2018) 156–162. doi: 10.1126/science.aat0271
124. [124]
  S. Ausländer, D. Ausländer, M. Fussenegger, Angew. Chem. Int. Ed. 56 (2017) 6396–6419. doi: 10.1002/anie.201609229
125. [125]
  D.N. Nesbeth, A. Zaikin, Y. Saka, et al., Essays Biochem. 60 (2016) 381–391. doi: 10.1042/EBC20160014
126. [126]
  Y. Lu, G. Allegri, J. Huskens, Mater. Horiz. 9 (2022) 892–907. doi: 10.1039/D1MH01431E
127. [127]
  G. Zubaite, J.W. Hindley, O. Ces, Y. Elani, ACS Nano 16 (2022) 9389–9400. doi: 10.1021/acsnano.2c02195
128. [128]
  Y.J. Li, J.Y. Wu, J. Liu, et al., J. Nanobiotechnology 19 (2021) 242. doi: 10.1186/s12951-021-00986-2
129. [129]
  U.T. Bornscheuer, Angew. Chem. Int. Ed. 49 (2010) 5228–5230. doi: 10.1002/anie.201003393
130. [130]
  Y. Ding, F. Wu, C. Tan, Life 4 (2014) 1092–1116. doi: 10.3390/life4041092
131. [131]
  P.L. Luisi, P. Stano, Nat. Chem. 3 (2011) 755–756. doi: 10.1038/nchem.1156
132. [132]
  A.N. Zelikin, B. Städler, Small 16 (2020) e2003442. doi: 10.1002/smll.202003442
133. [133]
  H. Seo, H. Lee, Nat. Commun. 13 (2022) 5179. doi: 10.1038/s41467-022-32889-7
134. [134]
  V. Noireaux, Y.T. Maeda, A. Libchaber, Proc. Natl. Acad. Sci. U. S. A. 108 (2011) 3473–3480. doi: 10.1073/pnas.1017075108
135. [135]
  J.A. Vance, N.K. Devaraj, J. Am. Chem. Soc. 143 (2021) 8223–8231. doi: 10.1021/jacs.1c03436
136. [136]
  Y. Ai, R. Xie, J. Xiong, Q. Liang, Small 16 (2020) e1903940. doi: 10.1002/smll.201903940
137. [137]
  X. Wang, H. Du, Z. Wang, et al., Adv. Mater. 33 (2021) e2002635. doi: 10.1002/adma.202002635
138. [138]
  A. Leathers, M. Walczak, R.A. Brady, et al., J. Am. Chem. Soc. 144 (2022) 17468–17476. doi: 10.1021/jacs.2c06140
139. [139]
  D. Gaur, N.C. Dubey, B.P. Tripathi, Adv. Colloid Interface Sci. 299 (2022) 102566. doi: 10.1016/j.cis.2021.102566
140. [140]
  B.C. Buddingh, J. Elzinga, J.C.M. van Hest, Nat. Commun. 11 (2020) 1652. doi: 10.1038/s41467-020-15482-8
141. [141]
  M. Dwidar, Y. Seike, S. Kobori, et al., J. Am. Chem. Soc. 141 (2019) 11103– 11114. doi: 10.1021/jacs.9b03300
142. [142]
  T. Mashima, M. van Stevendaal, F.R.A. Cornelissens, et al., Angew. Chem. Int. Ed. 61 (2022) e202115041. doi: 10.1002/anie.202115041
143. [143]
  N. Yin, W. Zhang, X.X. Sun, et al., Cell Rep. Med. 4 (2023) 101132. doi: 10.1016/j.xcrm.2023.101132
144. [144]
  Z. Chen, J. Wang, W. Sun, et al., Nat. Chem. Biol. 14 (2018) 86–93. doi: 10.1038/nchembio.2511
145. [145]
  N. Krinsky, M. Kaduri, A. Zinger, et al., Adv. Healthc. Mater. 7 (2018) e1701163. doi: 10.1002/adhm.201701163
146. [146]
  A. Wang, W. Fan, T. Yang, et al., Adv. Funct. Mater. 30 (2020) 1910168. doi: 10.1002/adfm.201910168
1. [1]
  Yuwen Zhu , Xiang Deng , Yan Wu , Baode Shen , Lingyu Hang , Yuye Xue , Hailong Yuan . Formation mechanism of herpetrione self-assembled nanoparticles based on pH-driven method. Chinese Chemical Letters, 2025, 36(1): 109733-. doi: 10.1016/j.cclet.2024.109733
2. [2]
  Yixin Zhang , Ting Wang , Jixiang Zhang , Pengyu Lu , Neng Shi , Liqiang Zhang , Weiran Zhu , Nongyue He . Formation mechanism for stable system of nanoparticle/protein corona and phospholipid membrane. Chinese Chemical Letters, 2024, 35(4): 108619-. doi: 10.1016/j.cclet.2023.108619
3. [3]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
4. [4]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
5. [5]
  Wei Su , Xiaoyan Luo , Peiyuan Li , Ying Zhang , Chenxiang Lin , Kang Wang , Jianzhuang Jiang . Phthalocyanine self-assembled nanoparticles for type Ⅰ photodynamic antibacterial therapy. Chinese Chemical Letters, 2024, 35(12): 109522-. doi: 10.1016/j.cclet.2024.109522
6. [6]
  Yiran Tao , Chunlei Dai , Zhaoxiang Xie , Xinru You , Kaiwen Li , Jun Wu , Hai Huang . Redox responsive polymeric nanoparticles enhance the efficacy of cyclin dependent kinase 7 inhibitor for enhanced treatment of prostate cancer. Chinese Chemical Letters, 2024, 35(8): 109170-. doi: 10.1016/j.cclet.2023.109170
7. [7]
  An Lu , Yuhao Guo , Yi Yan , Lin Zhai , Xiangyu Wang , Weiran Cao , Zijie Li , Zhixia Zhao , Yujie Shi , Yuanjun Zhu , Xiaoyan Liu , Huining He , Zhiyu Wang , Jian-Cheng Wang . Nanomedicine integrating the lipidic derivative of 5-fluorouracil, miriplatin and PD-L1 siRNA for enhancing tumor therapy. Chinese Chemical Letters, 2024, 35(6): 108928-. doi: 10.1016/j.cclet.2023.108928
8. [8]
  Yuqing Liu , Yu Yang , Yuhan E , Changlong Pang , Di Cui , Ang Li . Insight into microbial synthesis of metal nanomaterials and their environmental applications: Exploration for enhanced controllable synthesis. Chinese Chemical Letters, 2024, 35(11): 109651-. doi: 10.1016/j.cclet.2024.109651
9. [9]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
10. [10]
  Yanfei Liu , Yaqin Hu , Yifu Tan , Qiwen Chen , Zhenbao Liu . Tumor acidic microenvironment activatable DNA nanostructure for precise cancer cell targeting and inhibition. Chinese Chemical Letters, 2025, 36(1): 110289-. doi: 10.1016/j.cclet.2024.110289
11. [11]
  Yihao Zhang , Yang Jiao , Xianchao Jia , Qiaojia Guo , Chunying Duan . Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor. Chinese Chemical Letters, 2024, 35(5): 108748-. doi: 10.1016/j.cclet.2023.108748
12. [12]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
13. [13]
  Fereshte Hassanzadeh-Afruzi , Mina Azizi , Iman Zare , Ehsan Nazarzadeh Zare , Anwarul Hasan , Siavash Iravani , Pooyan Makvandi , Yi Xu . Advanced metal-organic frameworks-polymer platforms for accelerated dermal wound healing. Chinese Chemical Letters, 2024, 35(11): 109564-. doi: 10.1016/j.cclet.2024.109564
14. [14]
  Shenglan Zhou , Haijian Li , Hongyi Gao , Ang Li , Tian Li , Shanshan Cheng , Jingjing Wang , Jitti Kasemchainan , Jianhua Yi , Fengqi Zhao , Wengang Qu . Recent advances in metal-loaded MOFs photocatalysts: From single atom, cluster to nanoparticle. Chinese Chemical Letters, 2025, 36(1): 110142-. doi: 10.1016/j.cclet.2024.110142
15. [15]
  Zhilong Xie , Guohui Zhang , Ya Meng , Yefei Tong , Jian Deng , Honghui Li , Qingqing Ma , Shisong Han , Wenjun Ni . A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein. Chinese Chemical Letters, 2024, 35(11): 109584-. doi: 10.1016/j.cclet.2024.109584
16. [16]
  Lulu Cao , Yikun Li , Dongxiang Zhang , Shuai Yue , Rong Shang , Xin-Dong Jiang , Jianjun Du . Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy. Chinese Chemical Letters, 2024, 35(12): 109735-. doi: 10.1016/j.cclet.2024.109735
17. [17]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
18. [18]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
19. [19]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
20. [20]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420

Get Citation

PDF

XML

Metrics

PDF Downloads(5)
Abstract views(169)
HTML views(15)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142